XOMA Royalty (XOMA) Other financing activities (2012 - 2026)

XOMA Royalty (XOMA) reported Other financing activities of $565000.0 for Q1 2026, up 73.85% on a YoY basis from $325000.0 in Q1 2025, and down 65.21% sequentially from $1.6 million in Q4 2025.

XOMA Royalty (XOMA) Other financing activities (2012 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 13 years of Other financing activities data on file, last reported at $565000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities rose 73.85% year-over-year to $565000.0; the trailing twelve-month figure through Mar 2026 stood at $3.1 million (down 13.9% YoY), and the FY2025 full-year result was $5.0 million, down 3.22% from the prior year.
  • Other financing activities slipped to $565000.0 in Q1 2026, from $1.6 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.0 million in Q1 2024 to a low of $46000.0 in Q4 2022.
  • A 5-year average of $844307.7 and a median of $565000.0 in 2026 frame the typical range for Other financing activities.
  • Across the five-year window, Other financing activities soared 460.87% in 2023 and plunged 83.38% in 2025, its largest moves.
  • Tracing XOMA's Other financing activities over 5 years: stood at $46000.0 in 2022, then soared by 460.87% to $258000.0 in 2023, then jumped by 321.32% to $1.1 million in 2024, then soared by 49.4% to $1.6 million in 2025, then slumped by 65.21% to $565000.0 in 2026.
  • Business Quant data shows XOMA's Other financing activities at $565000.0 in Q1 2026, $1.6 million in Q4 2025, and $571000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 XOMA Royalty 478.42 Mn 412.34 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 565,000.00
Mar 31, 2026 565,000.00
Dec 31, 2025 1.62 Mn
Dec 31, 2025 1.62 Mn
Jun 30, 2025 571,000.00
Jun 30, 2025 571,000.00
Mar 31, 2025 325,000.00
Mar 31, 2025 325,000.00
Dec 31, 2024 1.09 Mn
Dec 31, 2024 1.09 Mn
Sep 30, 2024 1.77 Mn
Sep 30, 2024 1.77 Mn
Jun 30, 2024 397,000.00
Jun 30, 2024 397,000.00
Mar 31, 2024 1.96 Mn
Mar 31, 2024 1.96 Mn
Dec 31, 2023 258,000.00
Dec 31, 2023 258,000.00
Dec 31, 2022 46,000.00
Dec 31, 2022 46,000.00